Jonathan Rubin

Jonathan Rubin

Chief Tech/Sci/R&D Officer at SUPERNUS PHARMACEUTICALS, INC.

Net worth: 4 M $ as of 2026-05-30

64 year
Health Technology
Consumer Services
Consumer Durables

Profile

Jonathan Rubin is Senior VP-R&D, Chief Medical Officer at Supernus Pharmaceuticals, Inc. since 2021.
Former roles include Chief Medical Officer at Atentiv LLC from 2018 to 2020, Director-Medical Clinical Development at Shire Pharmaceuticals, Inc. from 2013 to 2017, Chief Medical Officer at Alcobra Ltd. from 2013 to 2017, Medical Director at Shire Development LLC, and other titles.
Education includes undergraduate studies at Yale University, an MBA from Columbia Business School, and a doctorate from The University of Connecticut School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.13%
2024-12-30 144,849 ( 0.13% ) 4 M $ 2026-05-30
2026-04-28 13,341 ( 0.02% ) 616 087 $ 2026-05-30

Jonathan Rubin active positions

CompaniesPositionStart
SUPERNUS PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2020-12-31

Former positions of Jonathan Rubin

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 2020-01-31
Chief Tech/Sci/R&D Officer 2017-08-31
Corporate Officer/Principal 2017-08-31
Shire Development LLC
Chief Tech/Sci/R&D Officer -
See the detail of Jonathan Rubin's experience

Training of Jonathan Rubin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

27

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Shire Development LLC

Consumer Durables

Technology Services

  1. Stock Market
  2. Insiders
  3. Jonathan Rubin